Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Neuromuscular Disorders : NMD|July 26, 2008
Electron microscopy in myofibrillar myopathies reveals clues to the mutated geneK G Claeys, M Fardeau, R Schröder, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2009
3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitorsAn T Vu, Stephen T Cohn, Eugene A Terefenko, et al.
Bioorganic & Medicinal Chemistry Letters|September 6, 2008
Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitorsCasey C McComas, An T Vu, Paige E Mahaney, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|July 3, 2007
Age-related bone mineral density, bone loss rate, prevalence of osteoporosis, and reference database of women at multiple centers in ChinaXiao-Guang Cheng, Ding-Zhuo Yang, Qi Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2009
Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitorsPaige E Mahaney, Callain Y Kim, Richard D Coghlan, et al.
Acta Crystallographica. Section D, Structural Biology|July 10, 2023
Module walking using an SH3-like cell-wall-binding domain leads to a new GH184 family of muramidasesOlga V Moroz, Elena Blagova, Andrey A Lebedev, et al.
Journal of Medicinal Chemistry|February 6, 2010
1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitorsAn T Vu, Stephen T Cohn, Puwen Zhang, et al.
Molecular Cancer Therapeutics|December 17, 2024
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic CancerVictoria M Valvo, Qiang Zhang, Long Jiang, et al.
Journal of Medicinal Chemistry|June 19, 2008
Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitorsPaige E Mahaney, Lori K Gavrin, Eugene J Trybulski, et al.
Pageof 25